ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ
Market Cap
$2.72B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
515 of 971
Rank in Industry
280 of 557
Largest Insider Buys in Sector
ACAD Stock Price History Chart
ACAD Stock Performance
About ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Activity of ACADIA Pharmaceuticals Inc.
Over the last 12 months, insiders at ACADIA Pharmaceuticals Inc. have bought $0 and sold $3.04M worth of ACADIA Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at ACADIA Pharmaceuticals Inc. have bought $31.9M and sold $12.58M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 294,154 shares for transaction amount of $7.45M was made by BAKER BROS. ADVISORS LP () on 2023‑05‑24.
List of Insider Buy and Sell Transactions, ACADIA Pharmaceuticals Inc.
| 2024-11-19 | Sale | EVP, COO, HEAD OF COMMERCIAL | 10,329 0.0065% | $16.81 | $173,630 | -3.45% | ||
| 2024-11-19 | Sale | EVP, CHIEF FINANCIAL OFFICER | 10,259 0.0064% | $16.81 | $172,454 | -3.45% | ||
| 2024-11-19 | Sale | PRINCIPAL ACCOUNTING OFFICER | 4,073 0.0025% | $16.81 | $68,467 | -3.45% | ||
| 2024-08-19 | Sale | CEO | 31,747 0.0186% | $15.28 | $485,094 | +1.08% | ||
| 2024-08-19 | Sale | EVP, COO, HEAD OF COMMERCIAL | 9,534 0.0056% | $15.28 | $145,680 | +1.08% | ||
| 2024-08-19 | Sale | EVP, CHIEF FINANCIAL OFFICER | 9,733 0.0057% | $15.28 | $148,720 | +1.08% | ||
| 2024-06-10 | Sale | EVP, CHIEF FINANCIAL OFFICER | 975 0.0006% | $14.79 | $14,420 | +6.12% | ||
| 2024-05-02 | Sale | CEO | 11,427 0.0069% | $16.94 | $193,573 | -8.44% | ||
| 2024-05-02 | Sale | EVP, COO, HEAD OF COMMERCIAL | 3,477 0.0021% | $16.94 | $58,900 | -8.44% | ||
| 2024-05-02 | Sale | EVP, CHIEF FINANCIAL OFFICER | 3,503 0.0021% | $16.94 | $59,341 | -8.44% | ||
| 2024-05-02 | Sale | PRINCIPAL ACCOUNTING OFFICER | 1,326 0.0008% | $16.94 | $22,462 | -8.44% | ||
| 2024-04-08 | Sale | CEO | 26,574 0.0162% | $17.87 | $474,877 | -11.12% | ||
| 2024-04-08 | Sale | EVP, COO, HEAD OF COMMERCIAL | 2,568 0.0016% | $17.87 | $45,890 | -11.12% | ||
| 2024-04-08 | Sale | EVP, CHIEF FINANCIAL OFFICER | 2,716 0.0017% | $17.87 | $48,535 | -11.12% | ||
| 2024-04-08 | Sale | PRINCIPAL ACCOUNTING OFFICER | 1,790 0.0011% | $17.87 | $31,987 | -11.12% | ||
| 2024-03-27 | Sale | CEO | 17,714 0.0106% | $17.90 | $317,081 | -12.39% | ||
| 2024-03-27 | Sale | EVP, COO, HEAD OF COMMERCIAL | 5,140 0.0031% | $17.90 | $92,006 | -12.39% | ||
| 2024-03-27 | Sale | EVP, CHIEF FINANCIAL OFFICER | 5,434 0.0032% | $17.90 | $97,269 | -12.39% | ||
| 2024-02-26 | Sale | CEO | 5,577 0.0032% | $24.67 | $137,585 | -37.07% | ||
| 2024-02-26 | Sale | EVP, COO, HEAD OF COMMERCIAL | 624 0.0004% | $24.67 | $15,394 | -37.07% |
Insider Historical Profitability
19.44%
| DAVIS STEPHEN | CEO | 186555 0.1121% | $16.32 | 0 | 30 | |
| Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 62105 0.0373% | $16.32 | 0 | 16 | |
| Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 53302 0.032% | $16.32 | 0 | 15 | |
| KIM AUSTIN D. | EVP,General Counsel, Secretary | 46901 0.0282% | $16.32 | 0 | 15 | |
| Kihara James | PRINCIPAL ACCOUNTING OFFICER | 19863 0.0119% | $16.32 | 0 | 14 | |
| BAKER BROS. ADVISORS LP | 39058564 23.4738% | $16.32 | 16 | 0 | +14.48% | |
| 14159, L.P. | 20278008 12.1869% | $16.32 | 1 | 0 | +3.15% | |
| BAKER FELIX | 18001203 10.8186% | $16.32 | 4 | 0 | +58.48% | |
| OXFORD BIOSCIENCE PARTNERS IV LP | 10 percent owner | 3160238 1.8993% | $16.32 | 2 | 0 | +29.7% |
| WALTON ALAN G | 2573836 1.5469% | $16.32 | 1 | 0 | +11.11% | |
| van Osch Martien | director | 1168892 0.7025% | $16.32 | 2 | 0 | +29.7% |
| GORDON CARL L | director | 774006 0.4652% | $16.32 | 2 | 0 | +29.7% |
| Brann Mark R | President & CSO | 317756 0.191% | $16.32 | 0 | 9 | |
| Hacksell Uli | CEO | 115549 0.0694% | $16.32 | 1 | 22 | +11.11% |
| Baity Glenn | EVP AND GC | 83734 0.0503% | $16.32 | 0 | 25 | |
| Stankovic Srdjan R. | President | 61234 0.0368% | $16.32 | 0 | 23 | |
| Iversen Leslie L | director | 36127 0.0217% | $16.32 | 1 | 4 | |
| Mills Roger | EVP, DEVELOPMENT AND CMO | 18550 0.0111% | $16.32 | 0 | 3 | |
| Brege Laura | director | 13502 0.0081% | $16.32 | 0 | 12 | |
| Ridloff Elena | EVP and CFO | 10553 0.0063% | $16.32 | 0 | 6 | |
| SOLAND DANIEL B | director | 10000 0.006% | $16.32 | 2 | 0 | <0.0001% |
| KAPLAN LESTER J PH D | director | 8500 0.0051% | $16.32 | 0 | 3 | |
| Rasmussen Torsten | director | 8500 0.0051% | $16.32 | 0 | 6 | |
| YANG MICHAEL J. | EVP and CCO | 8059 0.0048% | $16.32 | 0 | 7 | |
| Moore Terrence O | EVP, CHIEF COMMERCIAL OFFICER | 1671 0.001% | $16.32 | 0 | 4 | |
| HARRIGAN EDMUND | director | 1000 0.0006% | $16.32 | 1 | 0 | <0.0001% |
| Miller Eric Alejandro | Controller & PAO | 270 0.0002% | $16.32 | 0 | 3 | |
| BORER MICHAEL T | director | 0 0% | $16.32 | 0 | 2 | |
| GRAY MARY ANN | director | 0 0% | $16.32 | 0 | 3 | |
| Aasen Thomas H | EXEC VP, CFO AND CBO | 0 0% | $16.32 | 0 | 15 | |
| Lundstrom Brian | Sr. VP, Bus. Devt. | 0 0% | $16.32 | 0 | 5 | |
| Wells William McDowall | director | 0 0% | $16.32 | 0 | 4 | |
| Daly James M | director | 0 0% | $16.32 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Baker Bros Advisors LP | $792.57M | 25.94 | 42.86M | 0% | +$0 | 5.69 | |
| RTW Investments, LP | $255.7M | 8.37 | 13.83M | +22.89% | +$47.63M | 3.83 | |
| The Vanguard Group | $245.89M | 8.05 | 13.3M | -0.73% | -$1.8M | 0.01 | |
| BlackRock | $215.76M | 7.06 | 11.67M | +2.26% | +$4.78M | 0.01 | |
| State Street | $110.97M | 3.63 | 6M | -7.17% | -$8.57M | 0.01 | |
| Ecor1 Capital Llc | $110.78M | 3.63 | 5.99M | 0% | +$0 | 0.78 | |
| T. Rowe Price | $73.95M | 2.42 | 4M | -22.77% | -$21.8M | 0.01 | |
| Fidelity Investments | $73.85M | 2.42 | 3.99M | -24.15% | -$23.51M | 0.01 | |
| Geode Capital Management | $51.65M | 1.69 | 2.79M | +3.75% | +$1.87M | <0.01 | |
| D. E. Shaw & Co. | $48.85M | 1.6 | 2.64M | -29.63% | -$20.57M | 0.05 | |
| Palo Alto Investors Lp | $44.65M | 1.46 | 2.41M | +0.22% | +$99,605.63 | 5.04 | |
| Alger | $41.74M | 1.37 | 2.26M | -28.93% | -$17M | 0.21 | |
| Millennium Management LLC | $38.93M | 1.27 | 2.11M | +19.3% | +$6.3M | 0.03 | |
| Emerald Advisers, Inc. | $30.53M | 1 | 1.65M | +0.34% | +$102,785.91 | 1.24 | |
| First Trust | $30.49M | 1 | 1.65M | -7.23% | -$2.38M | 0.03 | |
| Jupiter Fund Management | $29.65M | 0.97 | 1.6M | +21.28% | +$5.2M | 0.08 | |
| Morgan Stanley | $27.05M | 0.89 | 1.46M | +7.42% | +$1.87M | <0.01 | |
| Voloridge Investment Management, LLC | $25.11M | 0.82 | 1.36M | +5.91% | +$1.4M | 0.09 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | $23.12M | 0.76 | 1.25M | -4.16% | -$1M | 1.21 | |
| Northern Trust | $22.04M | 0.72 | 1.19M | -1.84% | -$412,456.43 | <0.01 | |
| Charles Schwab | $21.99M | 0.72 | 1.19M | +5.42% | +$1.13M | 0.01 | |
| The Manufacturers Life Insurance Company | $21.66M | 0.71 | 1.17M | +38.48% | +$6.02M | 0.02 | |
| Prudential Financial | $19.83M | 0.65 | 1.07M | +142.09% | +$11.64M | 0.03 | |
| Deutsche Bank | $19.01M | 0.62 | 1.03M | +0.27% | +$51,882.94 | 0.01 | |
| Squarepoint Ops LLC | $18.66M | 0.61 | 1.01M | +264.19% | +$13.53M | 0.07 | |
| Connor Clark & Lunn Investment Management Ltd | $15.83M | 0.52 | 856,299 | +36.49% | +$4.23M | 0.04 | |
| FINEPOINT CAPITAL LP | $15.54M | 0.51 | 840,453 | +9.2% | +$1.31M | 2.5 | |
| Rockefeller Capital Management L P | $14.58M | 0.48 | 788,452 | +41.72% | +$4.29M | 0.04 | |
| Point72 Asset Management | $14.36M | 0.47 | 776,700 | +97.72% | +$7.1M | 0.02 | |
| Ameriprise Financial | $13.72M | 0.45 | 742,183 | +14.69% | +$1.76M | <0.01 | |
| Goldman Sachs | $13.46M | 0.44 | 727,905 | -9.48% | -$1.41M | <0.01 | |
| Panagora | $12.97M | 0.42 | 701,292 | +8.74% | +$1.04M | 0.07 | |
| Capital Fund Management | $12.86M | 0.42 | 695,547 | +185.28% | +$8.35M | 0.11 | |
| Rice Hall James & Associates, LLC | $12.29M | 0.4 | 664,556 | -4.08% | -$523,193.02 | 0.73 | |
| Canada Pension Plan Investment Board | $12.23M | 0.4 | 661,600 | New | +$12.23M | 0.01 | |
| Qube Research & Technologies | $11.91M | 0.39 | 644,070 | +129.81% | +$6.73M | 0.01 | |
| Avidity Partners Management Lp | $10.88M | 0.36 | 588,500 | New | +$10.88M | 0.41 | |
| Renaissance Technologies | $10.61M | 0.35 | 573,800 | +211.85% | +$7.21M | 0.02 | |
| Citadel Advisors LLC | $10.53M | 0.35 | 569,258 | +271.98% | +$7.7M | 0.01 | |
| Marshall Wace | $9.66M | 0.32 | 522,413 | New | +$9.66M | 0.01 | |
| Tang Capital Management, LLC | $9.59M | 0.31 | 518,900 | +353.58% | +$7.48M | 0.04 | |
| BNY Mellon | $9.3M | 0.3 | 503,053 | -8.69% | -$884,912.82 | <0.01 | |
| JPMorgan Chase | $8.78M | 0.29 | 475,004 | -28.13% | -$3.44M | <0.01 | |
| Frazier Life Sciences Management L P | $8.7M | 0.29 | 470,338 | -35.65% | -$4.82M | 0.39 | |
| Macquarie Group | $8.64M | 0.28 | 467,455 | +433.33% | +$7.02M | 0.01 | |
| Cubist Systematic Strategies | $8.35M | 0.27 | 451,518 | +17.2% | +$1.23M | 0.07 | |
| Nuveen | $8.1M | 0.27 | 437,878 | +4.99% | +$384,702.93 | <0.01 | |
| Candriam S C A | $7.5M | 0.25 | 405,751 | New | +$7.5M | 0.05 | |
| Rafferty Asset Management Llc | $7.23M | 0.24 | 391,225 | -8.58% | -$678,675.43 | 0.02 | |
| Jane Street Capital | $6.95M | 0.23 | 376,061 | -15.74% | -$1.3M | 0.01 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.